Miricorilant (Cohort A)
CORT118335-862
Phase 2 small_molecule active
Quick answer
Miricorilant (Cohort A) for Nonalcoholic Steatohepatitis (NASH) is a Phase 2 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CORCEPT THERAPEUTICS INC
- Indication
- Nonalcoholic Steatohepatitis (NASH)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active